Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360282 · ClinicalTrials.gov registry record · NA
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00360282 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 36 participants.
The verdict
NCT00360282, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
Interventions
- OTHER Placebo
- DRUG Rizatriptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-08 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360282
The ClinicalTrials.gov registry entry for NCT00360282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00360282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360282 about?
NCT00360282 is a clinical study titled "Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?". The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
What is the current status of trial NCT00360282?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2006-08. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00360282?
The interventions under investigation include: Placebo (OTHER), Rizatriptan (DRUG).
Who is sponsoring clinical trial NCT00360282?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.